Yabao Pharmaceutical Group Co. Ltd.SSE: 600351

(600351)"Yabao Pharmaceutical Group Co., Ltd."Announcement on Progress in Repurchasing Shares through Call Auction

· Issued by Yabao Pharmaceutical Group Co. Ltd. via Shanghai Stock Exchange

Filed with SSE · Stock code 600351 · · 2 pages · Chinese

Summary by 6ix AI

Yabao Pharmaceutical Group Co. Ltd. has announced progress in its share repurchase plan through a call auction. The company has repurchased a total of shares, representing a small percentage of its total capital, with specific price ranges for the transactions. The announcement includes details on the repurchase plan's implementation period and the total amount allocated for the buyback. The company assures compliance with relevant regulations and will continue to disclose updates on the repurchase progress.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

On 6ix: 6ix.com/news/600351yabao-pharmaceutical-group-co-ltdannouncement-on-progress-in-repurchasing-shares-through-call-auction

Release

Announcement on Progress in Repurchasing Shares through Call Auction

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

Yabao Pharmaceutical Group Co. Ltd. on 6ix

Story so far

Earlier from Yabao Pharmaceutical

Later from Yabao Pharmaceutical

All Yabao Pharmaceutical news releases